MSTN is also highly expressed in adipose tissues and is viewed as a potential target in obesity and type 2 diabetes mellitus because of the prominent role it plays in insulin-mediated glucose disposal and in determining the metabolic rate of SM [15,16,17]. This evidence concerns the gene MSTN and obesity due to melanocortin 4 receptor deficiency.